Toyota|$17.87 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.15 (¥3,981)+0.53%▲ (in JPY terms)
SoftBank|$29.83 (¥4,722)+3.69%▲ (in JPY terms)
MUFG|$21.64 (¥3,426)+2.24%▲ (in JPY terms)
Keyence|$516.79 (¥81,800)+1.10%▲ (in JPY terms)
Nintendo|$54.92 (¥8,693)+0.15%▲ (in JPY terms)
NTT|$1.11 (¥176)-0.62%▼ (in JPY terms)
Takeda|$40.10 (¥6,348)+0.60%▲ (in JPY terms)
Tokyo Electron|$64.88 (¥10,270)+1.83%▲ (in JPY terms)
Recruit|$120.48 (¥19,070)+1.44%▲ (in JPY terms)
ITOCHU|$14.62 (¥2,314)+0.70%▲ (in JPY terms)
Honda|$11.39 (¥1,804)-0.03%▼ (in JPY terms)
Shin-Etsu|$37.26 (¥5,898)+0.49%▲ (in JPY terms)
Tokio Marine|$3.52 (¥558)+2.44%▲ (in JPY terms)
Fast Retailing|$475.91 (¥75,330)-0.04%▼ (in JPY terms)
Toyota|$17.87 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.15 (¥3,981)+0.53%▲ (in JPY terms)
SoftBank|$29.83 (¥4,722)+3.69%▲ (in JPY terms)
MUFG|$21.64 (¥3,426)+2.24%▲ (in JPY terms)
Keyence|$516.79 (¥81,800)+1.10%▲ (in JPY terms)
Nintendo|$54.92 (¥8,693)+0.15%▲ (in JPY terms)
NTT|$1.11 (¥176)-0.62%▼ (in JPY terms)
Takeda|$40.10 (¥6,348)+0.60%▲ (in JPY terms)
Tokyo Electron|$64.88 (¥10,270)+1.83%▲ (in JPY terms)
Recruit|$120.48 (¥19,070)+1.44%▲ (in JPY terms)
ITOCHU|$14.62 (¥2,314)+0.70%▲ (in JPY terms)
Honda|$11.39 (¥1,804)-0.03%▼ (in JPY terms)
Shin-Etsu|$37.26 (¥5,898)+0.49%▲ (in JPY terms)
Tokio Marine|$3.52 (¥558)+2.44%▲ (in JPY terms)
Fast Retailing|$475.91 (¥75,330)-0.04%▼ (in JPY terms)

DAIICHI SANKYO COMPANY,LIMITED

2026-05-25 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (311.8KB) regarding the partial amendment approval of Datroway® (datopotamab deruxtecan) for the first-line treatment of triple-negative breast cancer in the United States will open in a new window.”

by

2026-05-25 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (311.8KB) regarding the partial amendment approv … 続きを読む

2026-05-18 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (277.7KB) regarding the approval of two partial changes to the Enhertu® (trastuzumab deruxtecan) drug for HER2-positive early-stage breast cancer in the United States will open in a new window.”

by

2026-05-18 DAIICHI SANKYO COMPANY,LIMITED “The PDF file (277.7KB) regarding the approval of two partial … 続きを読む

2026-05-11 DAIICHI SANKYO COMPANY,LIMITED “Notice of manufacturing and marketing approval in Japan for the dried attenuated live measles, mumps, and rubella combined vaccine "Mimlit® for subcutaneous injection" (176.8KB). (PDF file will open in a new window.)”

by

2026-05-11 DAIICHI SANKYO COMPANY,LIMITED “Notice of manufacturing and marketing approval in Japan for t … 続きを読む

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revision of the product supply plan and revisions to the consolidated earnings forecast for the full fiscal year ending March 2026 will be displayed in a new window.”

by

2026-05-08 DAIICHI SANKYO COMPANY,LIMITED “A PDF file (292.3KB) regarding losses incurred due to a revis … 続きを読む

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab deruxtecan (T-DXd/DS-8201) for HER2-positive breast cancer following neoadjuvant therapy in the United States (242.9 KB) PDF file opens in a new window.”

by

2026-03-09 DAIICHI SANKYO COMPANY,LIMITED “Submission of partial amendment for approval of trastuzumab d … 続きを読む

Contact